Meeting
2023 ASCO Annual Meeting
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
Authors
Carles Fabregat Franco
Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
Carles Fabregat Franco , Florian Castet , Adelaida La Casta , Jorge Adeva , Alfredo Castillo , Andrés Muñoz Sr., Paloma Peinado , Eva Martínez de Castro , Miriam Lobo , Monica Granja , Rosa Maria Rodriguez-Alonso , Ana Fernandez Montes , Ruth Vera , Javier Gallego , Begoña Graña , Ismael Ghanem , Inmaculada Alés , Raquel Molina , Teresa Macarulla , Enrique Aranda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4101)
DOI
10.1200/JCO.2023.41.16_suppl.4101
Abstract #
4101
Poster Bd #
422
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Pembrolizumab plus lenvatinib (P+L) versus alternate therapies in first-line (1L) for advanced renal cell carcinoma (aRCC): A network meta-analysis (NMA).
First Author: Kevin Yan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Surrogate endpoints for overall survival in advanced hepatocellular carcinoma: A meta-analysis.
First Author: Yacob Saleh
Poster
2017 Gastrointestinal Cancers Symposium
Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.
First Author: Kyung-Hun Lee
Poster
2014 ASCO Annual Meeting
An updated systematic review and meta-analysis of randomized controlled trials on duration of chemotherapy for advanced non-small cell lung cancer.
First Author: Yu Yang Soon